Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Author:
Lars H Lindholm,Hans Ibsen,Björn Dahlöf,Richard B Devereux,Gareth Beevers,Ulf de Faire,Frej Fyhrquist,Stevo Julius,Sverre E Kjeldsen,Krister Kristiansson,Ole Lederballe-Pedersen,Markku S Nieminen,Per Omvik,Suzanne Oparil,Hans Wedel,Peter Aurup et al.
Copyright © 2002 Elsevier Ltd. All rights reserved.